• レポートコード:GIR-2104Z06364 • 出版社/出版日:GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、107ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療・医薬品 |
Single User | ¥487,200 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥730,800 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、ジェネリック滅菌注射剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ジェネリック滅菌注射剤の種類別市場規模(モノクローナル抗体、サイトカイン、インスリン、ペプチドホルモン、ワクチン、その他)、用途別市場規模(病院、薬局、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ジェネリック滅菌注射剤の市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):3M、Baxter Inc、Fresenius Kabi、Pfizer/Hospira、Novartis/Sandoz、Teva、Hikma、Sun Pharma、Dr. Reddy’s、Mylan、AstraZeneca Plc、Merck & Co., Inc、Hellberg Safety Ab ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:モノクローナル抗体、サイトカイン、インスリン、ペプチドホルモン、ワクチン、その他 ・用途別分析2016年-2026年:病院、薬局、オンライン薬局 ・ジェネリック滅菌注射剤の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・ジェネリック滅菌注射剤のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・ジェネリック滅菌注射剤のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・ジェネリック滅菌注射剤の南米市場規模2016年-2026年:ブラジル、アルゼンチン ・ジェネリック滅菌注射剤の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Generic Sterile Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Generic Sterile Injectable size is estimated to be xx million in 2020 from USD 51320 million in 2019, with a change of XX% between 2019 and 2020. The global Generic Sterile Injectable market size is expected to grow at a CAGR of 5.5% for the next five years.
Market segmentation
Generic Sterile Injectable market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Vaccines
Others
Market segment by Application can be divided into
Hospitals
Pharmacies
Online Pharmacies
The key market players for global Generic Sterile Injectable market are listed below:
3M
Baxter Inc
Fresenius Kabi
Pfizer/Hospira
Novartis/Sandoz
Teva
Hikma
Sun Pharma
Dr. Reddy’s
Mylan
AstraZeneca Plc
Merck & Co., Inc
Hellberg Safety Ab
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Generic Sterile Injectable Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Generic Sterile Injectable Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Monoclonal Antibodies
1.2.3 Cytokines
1.2.4 Insulin
1.2.5 Peptide Hormones
1.2.6 Vaccines
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Generic Sterile Injectable Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Online Pharmacies
1.4 Global Generic Sterile Injectable Market Size & Forecast
1.4.1 Global Generic Sterile Injectable Sales in Value (2016-2026))
1.4.2 Global Generic Sterile Injectable Sales in Volume (2016-2026)
1.4.3 Global Generic Sterile Injectable Price by Type (2016-2026) & (USD/Unit)
1.5 Global Generic Sterile Injectable Production Capacity Analysis
1.5.1 Global Generic Sterile Injectable Total Production Capacity (2016-2026)
1.5.2 Global Generic Sterile Injectable Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Generic Sterile Injectable Market Drivers
1.6.2 Generic Sterile Injectable Market Restraints
1.6.3 Generic Sterile Injectable Trends Analysis
2 Manufacturers Profiles
2.1 3M
2.1.1 3M Details
2.1.2 3M Major Business
2.1.3 3M Generic Sterile Injectable Product and Services
2.1.4 3M Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Baxter Inc
2.2.1 Baxter Inc Details
2.2.2 Baxter Inc Major Business
2.2.3 Baxter Inc Generic Sterile Injectable Product and Services
2.2.4 Baxter Inc Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Generic Sterile Injectable Product and Services
2.3.4 Fresenius Kabi Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Pfizer/Hospira
2.4.1 Pfizer/Hospira Details
2.4.2 Pfizer/Hospira Major Business
2.4.3 Pfizer/Hospira Generic Sterile Injectable Product and Services
2.4.4 Pfizer/Hospira Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novartis/Sandoz
2.5.1 Novartis/Sandoz Details
2.5.2 Novartis/Sandoz Major Business
2.5.3 Novartis/Sandoz Generic Sterile Injectable Product and Services
2.5.4 Novartis/Sandoz Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Generic Sterile Injectable Product and Services
2.6.4 Teva Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Hikma
2.7.1 Hikma Details
2.7.2 Hikma Major Business
2.7.3 Hikma Generic Sterile Injectable Product and Services
2.7.4 Hikma Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Sun Pharma
2.8.1 Sun Pharma Details
2.8.2 Sun Pharma Major Business
2.8.3 Sun Pharma Generic Sterile Injectable Product and Services
2.8.4 Sun Pharma Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Dr. Reddy’s
2.9.1 Dr. Reddy’s Details
2.9.2 Dr. Reddy’s Major Business
2.9.3 Dr. Reddy’s Generic Sterile Injectable Product and Services
2.9.4 Dr. Reddy’s Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Generic Sterile Injectable Product and Services
2.10.4 Mylan Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 AstraZeneca Plc
2.11.1 AstraZeneca Plc Details
2.11.2 AstraZeneca Plc Major Business
2.11.3 AstraZeneca Plc Generic Sterile Injectable Product and Services
2.11.4 AstraZeneca Plc Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Merck & Co., Inc
2.12.1 Merck & Co., Inc Details
2.12.2 Merck & Co., Inc Major Business
2.12.3 Merck & Co., Inc Generic Sterile Injectable Product and Services
2.12.4 Merck & Co., Inc Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Hellberg Safety Ab
2.13.1 Hellberg Safety Ab Details
2.13.2 Hellberg Safety Ab Major Business
2.13.3 Hellberg Safety Ab Generic Sterile Injectable Product and Services
2.13.4 Hellberg Safety Ab Generic Sterile Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Generic Sterile Injectable Sales by Manufacturer
3.1 Global Generic Sterile Injectable Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Generic Sterile Injectable Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Generic Sterile Injectable
3.4 Market Concentration Rate
3.4.1 Top 3 Generic Sterile Injectable Manufacturer Market Share
3.4.2 Top 6 Generic Sterile Injectable Manufacturer Market Share
3.5 Global Generic Sterile Injectable Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Generic Sterile Injectable Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Generic Sterile Injectable Market Size by Region
4.1.1 Global Generic Sterile Injectable Sales in Volume by Region (2016-2026)
4.1.2 Global Generic Sterile Injectable Revenue by Region (2016-2026)
4.2 North America Generic Sterile Injectable Revenue (2016-2026)
4.3 Europe Generic Sterile Injectable Revenue (2016-2026)
4.4 Asia-Pacific Generic Sterile Injectable Revenue (2016-2026)
4.5 South America Generic Sterile Injectable Revenue (2016-2026)
4.6 Middle East and Africa Generic Sterile Injectable Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Generic Sterile Injectable Sales in Volume by Type (2016-2026)
5.2 Global Generic Sterile Injectable Revenue by Type (2016-2026)
5.3 Global Generic Sterile Injectable Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Generic Sterile Injectable Sales in Volume by Application (2016-2026)
6.2 Global Generic Sterile Injectable Revenue by Application (2016-2026)
6.3 Global Generic Sterile Injectable Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Generic Sterile Injectable Sales by Type (2016-2026)
7.2 North America Generic Sterile Injectable Sales by Application (2016-2026)
7.3 North America Generic Sterile Injectable Market Size by Country
7.3.1 North America Generic Sterile Injectable Sales in Volume by Country (2016-2026)
7.3.2 North America Generic Sterile Injectable Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Generic Sterile Injectable Sales by Type (2016-2026)
8.2 Europe Generic Sterile Injectable Sales by Application (2016-2026)
8.3 Europe Generic Sterile Injectable Market Size by Country
8.3.1 Europe Generic Sterile Injectable Sales in Volume by Country (2016-2026)
8.3.2 Europe Generic Sterile Injectable Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Generic Sterile Injectable Sales by Type (2016-2026)
9.2 Asia-Pacific Generic Sterile Injectable Sales by Application (2016-2026)
9.3 Asia-Pacific Generic Sterile Injectable Market Size by Region
9.3.1 Asia-Pacific Generic Sterile Injectable Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Generic Sterile Injectable Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Generic Sterile Injectable Sales by Type (2016-2026)
10.2 South America Generic Sterile Injectable Sales by Application (2016-2026)
10.3 South America Generic Sterile Injectable Market Size by Country
10.3.1 South America Generic Sterile Injectable Sales in Volume by Country (2016-2026)
10.3.2 South America Generic Sterile Injectable Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Generic Sterile Injectable Sales by Type (2016-2026)
11.2 Middle East & Africa Generic Sterile Injectable Sales by Application (2016-2026)
11.3 Middle East & Africa Generic Sterile Injectable Market Size by Country
11.3.1 Middle East & Africa Generic Sterile Injectable Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Generic Sterile Injectable Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Generic Sterile Injectable Typical Distributors
12.3 Generic Sterile Injectable Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Generic Sterile Injectable Revenue by Type, (USD Million), 2021-2026
Table 2. Global Generic Sterile Injectable Revenue by Application, (USD Million), 2021-2026
Table 3. 3M Basic Information, Manufacturing Base and Competitors
Table 4. 3M Major Business
Table 5. 3M Generic Sterile Injectable Product and Services
Table 6. 3M Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Baxter Inc Basic Information, Manufacturing Base and Competitors
Table 8. Baxter Inc Major Business
Table 9. Baxter Inc Generic Sterile Injectable Product and Services
Table 10. Baxter Inc Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 12. Fresenius Kabi Major Business
Table 13. Fresenius Kabi Generic Sterile Injectable Product and Services
Table 14. Fresenius Kabi Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer/Hospira Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer/Hospira Major Business
Table 17. Pfizer/Hospira Generic Sterile Injectable Product and Services
Table 18. Pfizer/Hospira Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis/Sandoz Basic Information, Manufacturing Base and Competitors
Table 20. Novartis/Sandoz Major Business
Table 21. Novartis/Sandoz Generic Sterile Injectable Product and Services
Table 22. Novartis/Sandoz Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Teva Basic Information, Manufacturing Base and Competitors
Table 24. Teva Major Business
Table 25. Teva Generic Sterile Injectable Product and Services
Table 26. Teva Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hikma Basic Information, Manufacturing Base and Competitors
Table 28. Hikma Major Business
Table 29. Hikma Generic Sterile Injectable Product and Services
Table 30. Hikma Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Sun Pharma Major Business
Table 33. Sun Pharma Generic Sterile Injectable Product and Services
Table 34. Sun Pharma Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Dr. Reddy’s Basic Information, Manufacturing Base and Competitors
Table 36. Dr. Reddy’s Major Business
Table 37. Dr. Reddy’s Generic Sterile Injectable Product and Services
Table 38. Dr. Reddy’s Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mylan Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Major Business
Table 41. Mylan Generic Sterile Injectable Product and Services
Table 42. Mylan Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Plc Major Business
Table 45. AstraZeneca Plc Generic Sterile Injectable Product and Services
Table 46. AstraZeneca Plc Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 48. Merck & Co., Inc Major Business
Table 49. Merck & Co., Inc Generic Sterile Injectable Product and Services
Table 50. Merck & Co., Inc Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Hellberg Safety Ab Basic Information, Manufacturing Base and Competitors
Table 52. Hellberg Safety Ab Major Business
Table 53. Hellberg Safety Ab Generic Sterile Injectable Product and Services
Table 54. Hellberg Safety Ab Generic Sterile Injectable Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Generic Sterile Injectable Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Generic Sterile Injectable Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Generic Sterile Injectable, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Generic Sterile Injectable Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Generic Sterile Injectable Production Site of Key Manufacturer
Table 60. Global Generic Sterile Injectable Sales by Region (2016-2021e) & (K Units)
Table 61. Global Generic Sterile Injectable Sales by Region (2021-2026) & (K Units)
Table 62. Global Generic Sterile Injectable Revenue by Region (2016-2021e) & (USD Million)
Table 63. Global Generic Sterile Injectable Revenue by Region (2021-2026) & (USD Million)
Table 64. Global Generic Sterile Injectable Sales by Type (2016-2021e) & (K Units)
Table 65. Global Generic Sterile Injectable Sales by Type (2021-2026) & (K Units)
Table 66. Global Generic Sterile Injectable Revenue by Type (2016-2021e) & (USD Million)
Table 67. Global Generic Sterile Injectable Revenue by Type (2021-2026) & (USD Million)
Table 68. Global Generic Sterile Injectable Price by Type (2016-2021e) & (USD/Unit)
Table 69. Global Generic Sterile Injectable Price by Type (2021-2026) & (USD/Unit)
Table 70. Global Generic Sterile Injectable Sales by Application (2016-2021e) & (K Units)
Table 71. Global Generic Sterile Injectable Sales by Application (2021-2026) & (K Units)
Table 72. Global Generic Sterile Injectable Revenue by Application (2016-2021e) & (USD Million)
Table 73. Global Generic Sterile Injectable Revenue by Application (2021-2026) & (USD Million)
Table 74. Global Generic Sterile Injectable Price by Application (2016-2021e) & (USD/Unit)
Table 75. Global Generic Sterile Injectable Price by Application (2021-2026) & (USD/Unit)
Table 76. North America Generic Sterile Injectable Sales by Country (2016-2021e) & (K Units)
Table 77. North America Generic Sterile Injectable Sales by Country (2021-2026) & (K Units)
Table 78. North America Generic Sterile Injectable Revenue by Country (2016-2021e) & (USD Million)
Table 79. North America Generic Sterile Injectable Revenue by Country (2021-2026) & (USD Million)
Table 80. North America Generic Sterile Injectable Sales by Type (2016-2021e) & (K Units)
Table 81. North America Generic Sterile Injectable Sales by Type (2021-2026) & (K Units)
Table 82. North America Generic Sterile Injectable Sales by Application (2016-2021e) & (K Units)
Table 83. North America Generic Sterile Injectable Sales by Application (2021-2026) & (K Units)
Table 84. Europe Generic Sterile Injectable Sales by Country (2016-2021e) & (K Units)
Table 85. Europe Generic Sterile Injectable Sales by Country (2021-2026) & (K Units)
Table 86. Europe Generic Sterile Injectable Revenue by Country (2016-2021e) & (USD Million)
Table 87. Europe Generic Sterile Injectable Revenue by Country (2021-2026) & (USD Million)
Table 88. Europe Generic Sterile Injectable Sales by Type (2016-2021e) & (K Units)
Table 89. Europe Generic Sterile Injectable Sales by Type (2021-2026) & (K Units)
Table 90. Europe Generic Sterile Injectable Sales by Application (2016-2021e) & (K Units)
Table 91. Europe Generic Sterile Injectable Sales by Application (2021-2026) & (K Units)
Table 92. Asia-Pacific Generic Sterile Injectable Sales by Region (2016-2021e) & (K Units)
Table 93. Asia-Pacific Generic Sterile Injectable Sales by Region (2021-2026) & (K Units)
Table 94. Asia-Pacific Generic Sterile Injectable Revenue by Region (2016-2021e) & (USD Million)
Table 95. Asia-Pacific Generic Sterile Injectable Revenue by Region (2021-2026) & (USD Million)
Table 96. Asia-Pacific Generic Sterile Injectable Sales by Type (2016-2021e) & (K Units)
Table 97. Asia-Pacific Generic Sterile Injectable Sales by Type (2021-2026) & (K Units)
Table 98. Asia-Pacific Generic Sterile Injectable Sales by Application (2016-2021e) & (K Units)
Table 99. Asia-Pacific Generic Sterile Injectable Sales by Application (2021-2026) & (K Units)
Table 100. South America Generic Sterile Injectable Sales by Country (2016-2021e) & (K Units)
Table 101. South America Generic Sterile Injectable Sales by Country (2021-2026) & (K Units)
Table 102. South America Generic Sterile Injectable Revenue by Country (2016-2021e) & (USD Million)
Table 103. South America Generic Sterile Injectable Revenue by Country (2021-2026) & (USD Million)
Table 104. South America Generic Sterile Injectable Sales by Type (2016-2021e) & (K Units)
Table 105. South America Generic Sterile Injectable Sales by Type (2021-2026) & (K Units)
Table 106. South America Generic Sterile Injectable Sales by Application (2016-2021e) & (K Units)
Table 107. South America Generic Sterile Injectable Sales by Application (2021-2026) & (K Units)
Table 108. Middle East & Africa Generic Sterile Injectable Sales by Country (2016-2021e) & (K Units)
Table 109. Middle East & Africa Generic Sterile Injectable Sales by Country (2021-2026) & (K Units)
Table 110. Middle East & Africa Generic Sterile Injectable Revenue by Country (2016-2021e) & (USD Million)
Table 111. Middle East & Africa Generic Sterile Injectable Revenue by Country (2021-2026) & (USD Million)
Table 112. Middle East & Africa Generic Sterile Injectable Sales by Type (2016-2021e) & (K Units)
Table 113. Middle East & Africa Generic Sterile Injectable Sales by Type (2021-2026) & (K Units)
Table 114. Middle East & Africa Generic Sterile Injectable Sales by Application (2016-2021e) & (K Units)
Table 115. Middle East & Africa Generic Sterile Injectable Sales by Application (2021-2026) & (K Units)
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Generic Sterile Injectable Typical Distributors
Table 119. Generic Sterile Injectable Typical Customers
List of Figures
Figure 1. Generic Sterile Injectable Picture
Figure 2. Global Generic Sterile Injectable Sales Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Cytokines
Figure 5. Insulin
Figure 6. Peptide Hormones
Figure 7. Vaccines
Figure 8. Others
Figure 9. Global Generic Sterile Injectable Sales Market Share by Application in 2020
Figure 10. Hospitals
Figure 11. Pharmacies
Figure 12. Online Pharmacies
Figure 13. Global Generic Sterile Injectable Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Generic Sterile Injectable Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. United States Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Canada Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Mexico Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Germany Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. France Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. United Kingdom Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Russia Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Italy Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. China Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Japan Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Korea Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. India Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Southeast Asia Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Australia Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Brazil Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Egypt Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Saudi Arabia Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. South Africa Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Turkey Generic Sterile Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Global Generic Sterile Injectable Sales (2016-2026) & (K Units)
Figure 35. Global Generic Sterile Injectable Production Capacity (2016-2026) & (K Units)
Figure 36. Global Generic Sterile Injectable Production Capacity by Geographic Region: 2020 VS 2021
Figure 37. Generic Sterile Injectable Market Drivers
Figure 38. Generic Sterile Injectable Market Restraints
Figure 39. Generic Sterile Injectable Market Trends
Figure 40. Global Generic Sterile Injectable Sales Market Share by Manufacturer in 2020
Figure 41. Global Generic Sterile Injectable Revenue Market Share by Manufacturer in 2020
Figure 42. Generic Sterile Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 43. Top 3 Generic Sterile Injectable Manufacturer (Revenue) Market Share in 2020
Figure 44. Top 6 Generic Sterile Injectable Manufacturer (Revenue) Market Share in 2020
Figure 45. Global Generic Sterile Injectable Sales Market Share by Region (2016-2026)
Figure 46. Global Generic Sterile Injectable Revenue Market Share by Region (2016-2026)
Figure 47. North America Generic Sterile Injectable Revenue (2016-2026) & (USD Million)
Figure 48. Europe Generic Sterile Injectable Revenue (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Generic Sterile Injectable Revenue (2016-2026) & (USD Million)
Figure 50. South America Generic Sterile Injectable Revenue (2016-2026) & (USD Million)
Figure 51. Middle East & Africa Generic Sterile Injectable Revenue (2016-2026) & (USD Million)
Figure 52. Global Generic Sterile Injectable Sales Market Share by Type (2016-2026)
Figure 53. Global Generic Sterile Injectable Revenue Market Share by Type (2016-2026)
Figure 54. Global Generic Sterile Injectable Price by Type (2016-2026) & (USD/Unit)
Figure 55. Global Generic Sterile Injectable Sales Market Share by Application (2016-2026)
Figure 56. Global Generic Sterile Injectable Revenue Market Share by Application (2016-2026)
Figure 57. Global Generic Sterile Injectable Price by Application (2016-2026) & (USD/Unit)
Figure 58. North America Generic Sterile Injectable Sales Market Share by Country (2016-2026)
Figure 59. North America Generic Sterile Injectable Revenue Market Share by Country (2016-2026)
Figure 60. North America Generic Sterile Injectable Sales Market Share by Type (2016-2026)
Figure 61. North America Generic Sterile Injectable Sales Market Share by Application (2016-2026)
Figure 62. Europe Generic Sterile Injectable Sales Market Share by Country (2016-2026)
Figure 63. Europe Generic Sterile Injectable Revenue Market Share by Country (2016-2026)
Figure 64. Europe Generic Sterile Injectable Sales Market Share by Type (2016-2026)
Figure 65. Europe Generic Sterile Injectable Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Generic Sterile Injectable Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Generic Sterile Injectable Revenue Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Generic Sterile Injectable Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Generic Sterile Injectable Sales Market Share by Application (2016-2026)
Figure 70. South America Generic Sterile Injectable Sales Market Share by Country (2016-2026)
Figure 71. South America Generic Sterile Injectable Revenue Market Share by Country (2016-2026)
Figure 72. South America Generic Sterile Injectable Sales Market Share by Type (2016-2026)
Figure 73. South America Generic Sterile Injectable Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Generic Sterile Injectable Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Generic Sterile Injectable Revenue Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Generic Sterile Injectable Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Generic Sterile Injectable Sales Market Share by Application (2016-2026)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source